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ABSTRACT 
In this commentary we discuss new findings presented by Shang et al. 
regarding the role of macrophage-derived glutamine in skeletal muscle 
repair. Loss-of-function of glutamate dehydrogenase in macrophages led 
to an upregulation of glutamine synthesis which sustained glutamine 
levels in muscle tissue and facilitated satellite cell proliferation and 
differentiation.  
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Macrophages are cells of the innate immune system that play a critical 
role in the regulation of inflammatory responses. Tissue resident 
macrophages contribute to organ development and homeostasis, whereas 
monocyte-derived macrophages are recruited upon tissue injury and 
coordinate tissue inflammation and repair. Up until recently, the 
inflammatory vs. reparative capacity of macrophages was often referred 
to as M1 or M2 activation states. However, it is now recognized that this 
terminology fails to describe the true diversity and plasticity of 
macrophage subsets in vivo [1]. Irrespective, it is well accepted that 
macrophages can promote tissue repair trough the clearance of dead cells, 
induction of angiogenesis, and regulation of matrix remodeling [2]. 
However, based on tissue location and mode of injury the mechanisms by 
which macrophages affect tissue repair may vary. Therefore, 
understanding the precise mechanisms utilized by these phagocytes to 
improve healing is of critical importance.  
Over the past decade it has been appreciated that macrophage cellular 
metabolism often dictates cell activation and effector functions. As an 
example, inflammatory macrophages are biased towards glycolytic 
metabolism whereas macrophages with reparative phenotypes tend to 
rely upon mitochondrial fatty acid oxidation [3,4]. However, it has become 
clear that this simple model of linking metabolic substrate use to effector 
phenotype is more complex than previously appreciated [5]. In addition, 
although the role of amino acid (AA) metabolism in macrophages is 
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gaining more attention, relatively little is known about AAs in macrophage 
activation states. That being said, the AA glutamine has long been known 
to influence immune cell activation and polarization and it is for this 
reason that most cell culture media contains an excess of glutamine. 
However, in the in vivo setting the availability and utilization of glutamine 
by macrophages in homeostasis and disease is less well understood. 
Skeletal muscle injury occurs in cases of trauma, muscular dystrophy, 
drug toxicity and aging. Macrophages contribute to skeletal muscle 
regeneration via several mechanisms including the release of cytokines 
that promote repair, such as IL-6 and TGFβ, and growth factors, including 
IGF-1, that can stimulate expansion of the muscle stem cells [6–8]. In an 
elegant recent study, Shang et.al. investigate the role of metabolites as 
mediators of crosstalk between macrophages and muscle satellite cells, an 
area which had not previously been explored. The authors describe a 
novel mechanism linking macrophage glutamine metabolism to muscle 
repair [9]. The authors used both cardiotoxin and femoral artery ligation 
models of skeletal muscle injury and first demonstrated that mice with a 
macrophage-specific knockout (KO) of glutamate dehydrogenase (Glud1), 
GLUD1 KO, had improved resolution of tissue damage and earlier 
restoration of functional capacity compared to wild type (WT) mice. This 
occurred as a consequence of enhanced proliferation of muscle satellite 
cells. Thus, perturbing macrophage glutamine metabolism enhanced 
muscle repair and regeneration.  
Intriguingly, macrophage recruitment and wound healing/angiogenic 
capacity were similar between the genotypes. Therefore, to understand 
the mechanism of this phenotype the authors performed metabolic 
phenotyping of GLUD1 KO macrophages. As GLUD1 catalyzes the 
conversion of glutamate to α-ketoglutarate for entry into the tricarboxylic 
acid (TCA) cycle it was not surprising that KO macrophages had a ~75% 
reduction in glutamine oxidation capacity. Intriguingly, the authors also 
demonstrated that macrophage glutamine production increased with the 
loss of GLUD1 and this was associated with an upregulation of the enzyme 
glutamine synthase (GS). Macrophage-specific KO of GS in GLUD1KO mice 
prevented the enhanced proliferation of muscle satellite cells that 
occurred with injury. Thus, loss of GLUD1 in macrophages promoted 
muscle regeneration via a GS-dependent mechanism. 
To understand the potential relevance of enhanced glutamine 
production to the crosstalk between macrophages and skeletal muscle 
cells the authors used an in vitro co-culture system. Glutamine is known 
to be important for myoblast proliferation. When WT macrophages were 
cultured with myoblasts in glutamine rich media the growth of myoblasts 
was diminished to levels observed under glutamine-restricted conditions. 
In contrast, this did not occur when myoblasts were cultured with GLUD1 
KO macrophages irrespective of the glutamine quantity added to the 
media. This data suggested that under normal conditions macrophages 
take up extracellular glutamine and thereby reduce the amount of this AA 
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that is available for use by myoblasts. In line with this observation, 
glutamine concentrations decreased in the muscle interstitial fluid 
following injury in WT mice and this drop did not occur in macrophage 
GLUD1 KO mice. As such, macrophages appear to compete with satellite 
cells for glutamine following muscle injury, influencing muscle 
regeneration.  
These findings suggested a model whereby glutamine release from 
GLUD1 KO macrophages enhanced glutamine availability and fueled 
muscle satellite cell expansion. To explore this possibility in more detail, 
the authors knocked out the primary receptor involved in glutamine 
uptake, SLC1A5, in satellite cells in vitro and in vivo using a CRISPR-Cas9 
approach. When satellite cell glutamine uptake was inhibited, the 
beneficial phenotype observed in macrophage GLUD1 KO mice was lost, 
confirming that glutamine released from macrophages was driving 
muscle regeneration. Similar results were observed in GLUD1 KO mice 
treated with the SLC1A5 inhibitor g-L-glutamyl-p-nitroanilide (GPNA). 
Together these findings confirm that the salutary effects of GLUD1 
deficiency in macrophages is dependent on glutamine delivery to satellite 
cells. Interestingly, the authors also confirmed a protective effect of 
macrophage GLUD1 deficiency on preservation of muscle mass with aging, 
indicating possible applications of this concept outside of acute injury.  
Despite the elegant mechanistic work performed by the authors, the 
question remained as to whether this pathway could be translated into 
therapeutics. Therefore, the investigators treated mice with the GLUD1 
inhibitor R162 after muscle injury. Inhibition of this enzyme also 
improved muscle regeneration and satellite cell proliferation. Moreover, 
in aged mice R162 treatment for one month improved muscle mass and 
exercise capacity. Thus, pharmacologic strategies targeting GLUD1 have 
promise for the treatment of acute and chronic muscle injury.  
The study by Shang et.al. is an exciting addition to the field of 
immunometabolism. The authors likely anticipated that disrupting 
glutamine oxidation in macrophages would have a direct effect on the 
macrophage polarization and thereby alter the injury response. Instead, 
they uncover a novel pathway whereby the release of glutamine from 
macrophages into the muscle microenvironment drove regeneration and 
healing. Equally as exciting, this study provides compelling evidence that 
this pathway could be exploited for therapeutic purposes (Figure 1).  
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Figure 1. Schematic illustrating the key findings of Shang et. al. study. In response to skeletal muscle 
injury macrophages enter the tissue and glutamine levels drop. In WT mice, macrophages compete with 
satellite cells (SC) for glutamine limiting the amount that is available to drive SC proliferation. In contrast, 
GLUD1 KO macrophages upregulate glutamine synthesis (GS) which leads to release of glutamine into the 
microenvironment. The glutamine enters SC via the receptor SLC1A5 and promotes SC proliferation, 
accelerating muscle regeneration. 
CONFLICTS OF INTEREST 
The author declares that he has no conflicts of interest. 
ACKNOWLEDGEMENTS 
This work was funded by R01 DK11003401.  
REFERENCES 
1. Artyomov MN, Sergushichev A, Schilling JD. Integrating immunometabolism 
and macrophage diversity. Semin Immunol. 2016;28(5):417-24. 
2. Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc 
Biol. 2013 Jun;93(6):875-81. 
3. Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva 
E, et al. Network integration of parallel metabolic and transcriptional data 
reveals metabolic modules that regulate macrophage polarization. Immunity. 
2015;42(3):419-30. 
4. OʼNeill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for 
immunologists. Nat Rev Immunol. 2016;16(9):553-65. 
Immunometabolism. 2021;3(2):e210013. https://doi.org/10.20900/immunometab20210013 
 
Immunometabolism 5 of 5 
5. Huang SC, Smith AM, Everts B, Colonna M, Pearce EL, Schilling JD, et al. 
Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is 
Essential for Macrophage Alternative Activation. Immunity. 2016;45(4):817-30. 
6. Baht GS, Bareja A, Lee DE, Rao RR, Huang R, Huebner JL, et al. Meteorin-like 
facilitates skeletal muscle repair through a Stat3/IGF-1 mechanism. Nat 
Metab. 2020;2(3):278-89. 
7. Saclier M, Yacoub-Youssef H, Mackey AL, Arnold L, Ardjoune H, Magnan M, 
et al. Differentially activated macrophages orchestrate myogenic precursor 
cell fate during human skeletal muscle regeneration. Stem Cells. 
2013;31(2):384-96. 
8. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, et al. 
Inflammatory monocytes recruited after skeletal muscle injury switch into 
antiinflammatory macrophages to support myogenesis. J Exp Med. 
2007;204(5):1057-69. 
9. Shang M, Cappellesso F, Amorim R, Serneels J, Virga F, Eelen G, et al. 
Macrophage-derived glutamine boosts satellite cells and muscle 




How to cite this article: 
Schilling JD. Macrophages Fuel Skeletal Muscle Regeneration. Immunometabolism. 2021;3(2):e210013. 
https://doi.org/10.20900/immunometab20210013  
 
Immunometabolism. 2021;3(2):e210013. https://doi.org/10.20900/immunometab20210013 
